1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethanone
- $336 - $1621
- Product name: 1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethanone
- CAS: 611220-24-7
- MF: C14H9Cl2FO
- MW: 283.13
- EINECS:
- MDL Number:MFCD16350604
- Synonyms:1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethanone;2',4'-Dichloro-2-(4-fluorophenyl)acetophenone;Ethanone, 1-(2,4-dichlorophenyl)-2-(4-fluorophenyl)-;1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethan-1-one;2',4'-DICHLORO-2-(4-FLUOROPHENYL)ACETOPHENONE
3 prices
Selected condition:
Brand
- Crysdot
- SynQuest Laboratories
Package
- 1g
- 5g
- ManufacturerCrysdot
- Product numberCD12055637
- Product description1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethanone 95+%
- Packaging1g
- Price$462
- Updated2021-12-16
- Buy
- ManufacturerCrysdot
- Product numberCD12055637
- Product description1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethanone 95+%
- Packaging5g
- Price$1621
- Updated2021-12-16
- Buy
- ManufacturerSynQuest Laboratories
- Product number2617-7-49
- Product description2',4'-Dichloro-2-(4-fluorophenyl)acetophenone
- Packaging1g
- Price$336
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Crysdot | CD12055637 | 1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethanone 95+% | 1g | $462 | 2021-12-16 | Buy |
Crysdot | CD12055637 | 1-(2,4-Dichlorophenyl)-2-(4-fluorophenyl)ethanone 95+% | 5g | $1621 | 2021-12-16 | Buy |
SynQuest Laboratories | 2617-7-49 | 2',4'-Dichloro-2-(4-fluorophenyl)acetophenone | 1g | $336 | 2021-12-16 | Buy |
Properties
Boiling point :376.0±32.0 °C(Predicted)
Density :1.349±0.06 g/cm3(Predicted)
storage temp. :2-8°C
Density :1.349±0.06 g/cm3(Predicted)
storage temp. :2-8°C
Safety Information
Symbol(GHS): | |||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||||||||||||||||
Precautionary statements: |
|